Frontlight ResearchEarly access
Crohn's disease trials in Switzerland
1 of 12 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
- Where
- Bern
- Age
- 18 years and over
- People
- 50
- Run by
- Janssen-Cilag A.G., Switzerland
See details and how to joinNCT07532213